FLUMIST QUADRIVALENT
FLUMIST QUADRIVALENT
Approved
DIN Number
02426544
Drug Class
Human
Market Date
Oct 10, 2014
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02426544
AIG Number0455811001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB03 INFLUENZA, LIVE ATTENUATED
Product Specifications
Dosage FormSpray
Route of AdministrationNasal
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
INFLUENZA VIRUS TYPE A (H1N1)Active
Strength: 32000000 FFU / 0.2 ML
Monograph: INFLUENZA VIRUS TYPE A (H1N1)
INFLUENZA VIRUS TYPE A (H3N2)Active
Strength: 32000000 FFU / 0.2 ML
Monograph: INFLUENZA VIRUS TYPE A (H3N2)
INFLUENZA VIRUS TYPE B (VICTORIA)Active
Strength: 32000000 FFU / 0.2 ML
Monograph: INFLUENZA VIRUS TYPE B (VICTORIA)
INFLUENZA VIRUS TYPE B (YAMAGATA)Active
Strength: 32000000 FFU / 0.2 ML
Monograph: INFLUENZA VIRUS TYPE B (YAMAGATA)